350 related articles for article (PubMed ID: 25074664)
1. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis.
Shen W; Sakamoto N; Yang L
Ann Surg Oncol; 2015 Jan; 22(1):264-71. PubMed ID: 25074664
[TBL] [Abstract][Full Text] [Related]
2. Model to Predict Cause-Specific Mortality in Patients with Head and Neck Adenoid Cystic Carcinoma: A Competing Risk Analysis.
Shen W; Sakamoto N; Yang L
Ann Surg Oncol; 2017 Aug; 24(8):2129-2136. PubMed ID: 28424937
[TBL] [Abstract][Full Text] [Related]
3. Population-based study of competing mortality in head and neck cancer.
Rose BS; Jeong JH; Nath SK; Lu SM; Mell LK
J Clin Oncol; 2011 Sep; 29(26):3503-9. PubMed ID: 21844503
[TBL] [Abstract][Full Text] [Related]
4. Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.
Zhou H; Zhang Y; Qiu Z; Chen G; Hong S; Chen X; Zhang Z; Huang Y; Zhang L
Clin Lung Cancer; 2018 Mar; 19(2):e195-e203. PubMed ID: 29153966
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
[TBL] [Abstract][Full Text] [Related]
6. Nomograms predicting long-term overall survival and cancer-specific survival in head and neck squamous cell carcinoma patients.
Ju J; Wang J; Ma C; Li Y; Zhao Z; Gao T; Ni Q; Sun M
Oncotarget; 2016 Aug; 7(32):51059-51068. PubMed ID: 27419636
[TBL] [Abstract][Full Text] [Related]
7. Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis.
Shen W; Sakamoto N; Yang L
BMC Cancer; 2016 Jul; 16():413. PubMed ID: 27389173
[TBL] [Abstract][Full Text] [Related]
8. Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer.
Yang L; Shen W; Sakamoto N
J Clin Oncol; 2013 Feb; 31(4):468-74. PubMed ID: 23270002
[TBL] [Abstract][Full Text] [Related]
9. Competing causes of death in the head and neck cancer population.
Massa ST; Osazuwa-Peters N; Christopher KM; Arnold LD; Schootman M; Walker RJ; Varvares MA
Oral Oncol; 2017 Feb; 65():8-15. PubMed ID: 28109473
[TBL] [Abstract][Full Text] [Related]
10. Grade as a prognostic factor in oral squamous cell carcinoma: a population-based analysis of the data.
Thomas B; Stedman M; Davies L
Laryngoscope; 2014 Mar; 124(3):688-94. PubMed ID: 23945976
[TBL] [Abstract][Full Text] [Related]
11. Development of comprehensive nomograms for evaluating overall and cancer-specific survival of laryngeal squamous cell carcinoma patients treated with neck dissection.
Shi X; Hu WP; Ji QH
Oncotarget; 2017 May; 8(18):29722-29740. PubMed ID: 28430613
[TBL] [Abstract][Full Text] [Related]
12. A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma.
Wu X; Yu W; Petersen RH; Sheng H; Wang Y; Lv W; Hu J
BMC Cancer; 2020 May; 20(1):429. PubMed ID: 32416716
[TBL] [Abstract][Full Text] [Related]
13. Risk of superficial squamous cell carcinoma developing in the head and neck region in patients with esophageal squamous cell carcinoma.
Katada C; Muto M; Nakayama M; Tanabe S; Higuchi K; Sasaki T; Azuma M; Ishido K; Katada N; Yamashita K; Nemoto M; Shibata T; Masaki T; Okamoto M; Koizumi W
Laryngoscope; 2012 Jun; 122(6):1291-6. PubMed ID: 22674532
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
[TBL] [Abstract][Full Text] [Related]
15. A Competing-Risks Nomogram in Patients with Metastatic Pancreatic Duct Adenocarcinoma.
Lu Y; Zhou Y; Cao Y; Shi Z; Meng Q
Med Sci Monit; 2019 May; 25():3683-3691. PubMed ID: 31102397
[TBL] [Abstract][Full Text] [Related]
16. Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysis.
Li J; Zheng Q; Zhao X; Zhao J; An T; Wu M; Wang Y; Zhuo M; Zhong J; Yang X; Jia B; Chen H; Dong Z; Wang J; Chi Y; Zhai X; Wang Z
BMC Cancer; 2020 Aug; 20(1):793. PubMed ID: 32838776
[TBL] [Abstract][Full Text] [Related]
17. The impact of compliance in posttreatment surveillance in head and neck squamous cell carcinoma.
Deutschmann MW; Sykes KJ; Harbison J; Cabrera-Muffly C; Shnayder Y
JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):519-25. PubMed ID: 25950859
[TBL] [Abstract][Full Text] [Related]
18. Causes of death in long-term survivors of head and neck cancer.
Baxi SS; Pinheiro LC; Patil SM; Pfister DG; Oeffinger KC; Elkin EB
Cancer; 2014 May; 120(10):1507-13. PubMed ID: 24863390
[TBL] [Abstract][Full Text] [Related]
19. Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.
Gourin CG; McAfee WJ; Neyman KM; Howington JW; Podolsky RH; Terris DJ
Laryngoscope; 2005 Aug; 115(8):1371-5. PubMed ID: 16094107
[TBL] [Abstract][Full Text] [Related]
20. Nomograms for preoperative prediction of prognosis in patients with oral cavity squamous cell carcinoma.
Montero PH; Yu C; Palmer FL; Patel PD; Ganly I; Shah JP; Shaha AR; Boyle JO; Kraus DH; Singh B; Wong RJ; Morris LG; Kattan MW; Patel SG
Cancer; 2014 Jan; 120(2):214-21. PubMed ID: 24399417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
